Selective rescue of early haematopoietic progenitors in Scl–/– mice by expressing Scl under the control of a stem cell enhancer
Author:
Sánchez María-José1, Bockamp Ernesto-Otto2, Miller Jane1, Gambardella Laure1, Green Anthony R.1
Affiliation:
1. University of Cambridge, Department of Haematology, CIMR Centre, Hills Road, Cambridge CB2 2XY, UK 2. Johannes Gutenberg-University, Institute of Toxicology, Laboratory of Molecular Mouse Genetics, Obere Zahlbacher Str. 67, 55131 Mainz, Germany
Abstract
The stem cell leukaemia gene (Scl) encodes a basic helix-loop-helix transcription factor with a pivotal role in both haematopoiesis and endothelial development. During mouse development, Scl is first expressed in extra-embryonic mesoderm, and is required for the generation of all haematopoietic lineages and normal yolk sac angiogenesis. Ectopic expression of Scl during zebrafish development specifies haemangioblast formation from early mesoderm. These results suggest that SCL is essential for establishing the transcriptional programme responsible for the formation of haematopoietic stem cells and have focused attention on the transcriptional regulation of Scl itself. Previous studies have identified a panel of Scl enhancers each of which directed expression to a subdomain of the normal Scl expression pattern. Among them, a 3′ enhancer directed expression during development to vascular endothelium and haematopoietic progenitors but not to Ter119+ erythroid cells. The expression in haematopoietic stem cells, however, remained undetermined. We demonstrate that this 3′ enhancer directs lacZ expression in transgenic mice to most foetal and adult long-term repopulating haematopoietic stem cells, and therefore functions as a stem cell enhancer. Consistent with these results, expression in Scl–/– embryos of exogenous Scl driven by the stem cell enhancer rescued the formation of early haematopoietic progenitors and also resulted in normal yolk sac angiogenesis. By contrast, erythropoiesis remained markedly deficient in rescued embryos. This observation is consistent with the inactivity of the stem cell enhancer in erythroid cells and reveals an essential role for SCL during erythroid differentiation in vivo.
Publisher
The Company of Biologists
Subject
Developmental Biology,Molecular Biology
Reference79 articles.
1. Aplan, P. D., Nakahara, K., Orkin, S. H. and Kirsch, I. R. (1992). The SCL gene product: a positive regulator of erythroid differentiation. EMBO J.11, 4073-4081. 2. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G. and Isner, J. M. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science275, 964-967. 3. Begley, C. G. and Green, A. R. (1999). The SCL gene: from case report to critical hematopoietic regulator. Blood93, 2760-2770. 4. Bockamp, E. O., McLaughlin, F., Murrell, A. M., Gottgens, B., Robb, L., Begley, C. G. and Green, A. R. (1995). Lineage-restricted regulation of the murine SCL/TAL-1 promoter. Blood86, 1502-1514. 5. Bockamp, E. O., McLaughlin, F., Gottgens, B., Murrell, A. M., Elefanty, A. G. and Green, A. R. (1997). Distinct mechanisms direct SCL/tal-1 expression in erythroid cells and CD34 positive primitive myeloid cells. J. Biol. Chem.272, 8781-8790.
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|